The allegations – made by media firm Fairfax – focus on a three-year-old deal between Novartis and DataTrace DNA, a joint venture originally set up by Australia’s national Commonwealth Scientific and Industrial Research Organisation (CSIRO) and DataDot Technology Ltd.
According to the report, DataTrace knowingly passed off basic chemicals as a unique tracer to mark vials of Voltaren (diclofenac), an injectable anti-inflammatory drug used to treat arthritis.
More information available at : click here